Literature DB >> 16220456

[Liver metastases: incidence and histogenesis].

H-U Kasper1, U Drebber, V Dries, H P Dienes.   

Abstract

Metastases are the most common malignant tumors of the liver. In the files of the Institute of Pathology of the University of Cologne 12,161 liver tissue cases are registered. Of them, 1,357 cases (11.2%) showed tumors or tumor like masses. Liver metastases of solid tumors were the largest group of the neoplasias with 611 cases (5.0%) followed by hepatocellular carcinoma (380 cases; 3.1%). Other entities were rare and include cholangiolar carcinoma (0.5%), vascular tumors (0.4%), lymphomas (0.4%), focal nodular hyperplasias (0.36%) and liver cell adenomas (0.23%). Adenocarcinomaa are the largest group of metastases with 400 cases (65.5%). 48.2% of this group were metastases of colorectal cancer, 13.5% of pancreatic cancer, 13% of breast cancer, 6.2% of gastric cancer, 4.5% of lung cancer and 3.7% of esophageal cancer. Neuroendocrine carcinomas are the second largest group with 16% of liver filiae. Other entities were rarely found. Metastases in cirrhotic livers are seldom. The gross findings, the histology, the differential diagnosis including immunohistochemistry and the value of the liver biopsy is discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16220456     DOI: 10.1055/s-2005-858576

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  12 in total

1.  Poorly Differentiated Neuroendocrine Carcinoma of the Sigmoid Colon-a Rare Differential Diagnosis of Malignant Colon Tumours.

Authors:  Ahmed Abdel Samie; Rui Sun; Afshin Fayyazi; Lorenz Theilmann
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 2.  Radioembolization of hepatic tumors.

Authors:  Andrew Kennedy
Journal:  J Gastrointest Oncol       Date:  2014-06

Review 3.  SIRT of liver metastases: physiological and pathophysiological considerations.

Authors:  Christophe Van de Wiele; Alex Maes; Eddy Brugman; Yves D'Asseler; Bart De Spiegeleer; Gilles Mees; Karin Stellamans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-17       Impact factor: 9.236

Review 4.  [Diagnostic imaging of liver tumours. Current status].

Authors:  B Boozari; J Lotz; M Galanski; M Gebel
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

5.  Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent.

Authors:  Peter Reimer; Rolf Vosshenrich
Journal:  Biologics       Date:  2010-08-09

Review 6.  Treatment of metastatic liver tumors using stereotactic ablative radiotherapy.

Authors:  Vimoj J Nair; Jason R Pantarotto
Journal:  World J Radiol       Date:  2014-02-28

7.  Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer.

Authors:  Thomas J Vogl; Nagy N N Naguib; Nour-Eldin A Nour-Eldin; Katrin Eichler; Stefan Zangos; Tatjana Gruber-Rouh
Journal:  Eur Radiol       Date:  2009-08-06       Impact factor: 5.315

8.  Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells.

Authors:  Juliet Padden; Maike Ahrens; Julia Kälsch; Stefanie Bertram; Dominik A Megger; Thilo Bracht; Martin Eisenacher; Peri Kocabayoglu; Helmut E Meyer; Bence Sipos; Hideo A Baba; Barbara Sitek
Journal:  Mol Cell Proteomics       Date:  2015-12-07       Impact factor: 5.911

9.  Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.

Authors:  Christian Wybranski; Martin Zeile; David Löwenthal; Frank Fischbach; Maciej Pech; Friedrich-Wilhelm Röhl; Günther Gademann; Jens Ricke; Oliver Dudeck
Journal:  Radiat Oncol       Date:  2011-04-27       Impact factor: 3.481

10.  Neuroendocrine neoplasms of liver - A 5-year retrospective clinico-pathological study applying World Health Organization 2010 classification.

Authors:  Deepak Kalyansingh Burad; Thomas Alex Kodiatte; Sayd Mohamed Rajeeb; Ashish Goel; Chundamannil Eapen Eapen; Banumathi Ramakrishna
Journal:  World J Gastroenterol       Date:  2016-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.